At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders
In Brief
A Phase 3 clinical trial evaluating Platelet-Rich Plasma intramuscular injections and Placebo Comparator: 0,9% NaCl intramuscular injections for PRP and 3 related conditions. Completed, enrolled 58 participants across 1 site.
Detailed Summary
The Platelet-Rich Plasma intramuscular injections into the masseter and temporalis muscle were performed to reduce painful temporomandibular disorder symptoms,such as myalgia, myofascial pain and myofascial pain with referrals. Patients(n=120) were randomly divided into two groups: experimental(n=60) and control group(n=60). In controls injections with 0,9% NaCl were performed. Pain intensity was measured with NPRS (numeriic pain rating scale, 0= no pain, 11= the worst pain that one can imagine) before(0 day), during(10 day) and after(20 day) the therapy with PRP injections.
Study Details
Timeline
Interventions
A platelet-rich plasma intramuscular injections into the trigger points of painful muscles were performed.
A 0,9% NaCl intramuscular injections into the trigger points of painful muscles were performed.